BIOCONNSEBiocon Limited· PharmaceuticalsMediumNeutral
Announced Wed, 9 Jul · 20:10 IST

Biocon Limited has informed the Exchange about outcome of Board Meeting - Appointment of Interim Company Secretary and Compliance Officer

Management Changes View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biocon Limited's Board of Directors, at a meeting held on July 9, 2025, approved the appointment of Ms. Ekta Agarwal as the Interim Company Secretary and Compliance Officer (a Key Managerial Personnel role) effective July 10, 2025. The appointment was made on the recommendation of the Nomination and Remuneration Committee under SEBI Listing Regulations and Section 203 of the Companies Act, 2013. Ms. Agarwal is a qualified Company Secretary and Fellow Member of ICSI with over 11 years of experience in corporate secretarial and compliance functions. She will serve in this interim capacity until a permanent Company Secretary and Compliance Officer is appointed by the Board.

Likely market impact

This is a routine governance update to fill the Company Secretary position on an interim basis. It is unlikely to have a material impact on the stock price, though it ensures the company remains compliant with SEBI's KMP requirements during the transition.